Vistagen Therapeutics, Inc. (VTGN) Net margin 2017–2026
Vistagen Therapeutics, Inc. (VTGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-5491.3%FY2026 · since FY2017: -820.4% → -5491.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -5491.3% | +5088.5 pp |
| FY2025 | -10579.8% | -7820.2 pp |
| FY2024 | -2759.6% | — |
| FY2022 | -4306.8% | -2660.7 pp |
| FY2021 | -1646.1% | — |
| FY2017 | -820.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice